In 2023, Oneness Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Oneness Biotech has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 |
|---|---|
Total Scope 1 | 183.717a |
Total Scope 2 | |
Unspecified Calculation Method | 1,530.006a |
Total Scope 3 | 648.799a |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 64.9422a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of Oneness Biotech amounted to 1,713.723 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
In 2023, the total Scope 1 emissions of Oneness Biotech were 183.717 metric tons of CO₂ equivalent (tCO₂e).a
In 2023, Oneness Biotech reported Scope 2 greenhouse gas (GHG) emissions of 1,530.006 tCO₂e without specifying the calculation method.a
In 2023, Oneness Biotech reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Oneness Biotech reported 648.799 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2023 disclosure of Oneness Biotech includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2023, Oneness Biotech reported total Scope 3 emissions of 648.799 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
In 2023, Oneness Biotech reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2023, the largest contributors to Oneness Biotech's Scope 3 emissions were:a
In 2023, Oneness Biotech reported Scope 1 greenhouse gas (GHG) emissions of 183.717 tCO₂e and total revenues of USD 3 millions. This translates into an emissions intensity of 64.94 tCO₂e per millions USD.a
In 2023, Oneness Biotech reported a Scope 1 emissions intensity of 64.94 tCO₂e per millions USD. Compared to the peer group median of 4.12, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2023, Oneness Biotech ranked 17 out of 19 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Oneness Biotech among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2023, Oneness Biotech reported a total carbon footprint of 2,362.522 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions.a
The largest contributor to Oneness Biotech's total carbon footprint was Scope 2 emissions, accounting for 64.76% of the company's total carbon footprint, followed by Scope 3 emissions at 27.46%.a